[Pharmacological treatment for pregnancy and lactation associated osteoporosis]

Clin Calcium. 2019;29(1):70-76.
[Article in Japanese]

Abstract

Pregnancy and lactation associated osteoporosis(PLO)is a rare disorder for women during pregnancy, the post-partum period, or while breastfeeding. It still remains unknown factors in its pathogenesis. That makes it there is no evident strategy for PLO now. In most cases, bone mineral density(BMD)of PLO patients spontaneously recovers after giving lactation up. On the other hand, patients with severe cases sometimes need bone specific therapy. There are some reports that show bisphosphonate, teriparatide and/or denosumab are effective on PLO cases. When the patients have wishes for having babies, we have to pay attention if the prescription effect on next pregnancy.

MeSH terms

  • Bone Density
  • Bone Density Conservation Agents*
  • Female
  • Humans
  • Lactation
  • Osteoporosis* / physiopathology
  • Pregnancy
  • Teriparatide / metabolism*

Substances

  • Bone Density Conservation Agents
  • Teriparatide